In this episode of the Mama Rae Podcast, we explore the rising conversation around psychedelics—including LSD and psilocybin—through both a scientific and Lutheran theological lens.

Drawing from research conducted by Johns Hopkins Medicine and other leading institutions, we examine how psychedelics are being studied for their potential to treat depression, PTSD, and addiction—while also asking deeper questions about consciousness, spirituality, and truth.

Clinical studies have shown that psilocybin-assisted therapy can produce rapid and sustained antidepressant effects, with some patients experiencing relief lasting months to even years when combined with guided psychotherapy . In some long-term follow-ups, a significant portion of participants remained in remission years after treatment .

Researchers also note that psychedelic experiences are often described as deeply meaningful or “mystical,” and those experiences are sometimes linked to improved mental health outcomes .

However, these substances are not currently FDA-approved treatments and are only being used within controlled clinical trials .

So what does it mean when a chemical can produce an experience that feels spiritual?

Is it healing?

Is it neurological?

Or is it something we don’t fully understand?

Through a Lutheran lens, we explore:

• The importance of sobriety and clarity of mind

• Whether altered states can be trusted as truth

• And how to discern between spiritual experience and brain-generated perception

This episode sits at the intersection of:

✨ Neuroscience

✨ Faith

✨ Consciousness

✨ And the human longing for connection

🔖 VERIFIED SOURCES

🧠 Johns Hopkins & Clinical Research

• Johns Hopkins Center for Psychedelic and Consciousness Research

• Psychedelics are being studied for therapeutic potential but are not yet approved treatments 

• Johns Hopkins Medicine

• Psilocybin-assisted therapy has shown significant reduction in depression symptoms, lasting up to a year or more in some patients 

• Randomized clinical trial (JAMA Psychiatry)

• Found “large, rapid, and sustained antidepressant effects” from psilocybin with therapy 

• Long-term follow-up research

• Up to 67% of participants remained in remission years later 

🧠 Psychological & Experiential Findings

• Psychedelic experiences often rated as:

• Highly meaningful

• Spiritually significant

• Linked to improved well-being 

⚠️ Important Context

• Psychedelics:

• Are still controlled substances

• Are being studied only in guided, clinical settings

• Require more research on safety, long-term effects, and ethical use